Shan Dong Kexing Bioproducts Co Ltd
688136
Company Profile
Business description
Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.
Contact
No. 2666, Chuangye Road
Mingshui Development Zone
Zhangqiu District
Shandong Province
Jinan250200
CHNT: +86 75586967773
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
1,048
Stocks News & Analysis
stocks
ASX iron ore player downgraded ahead of earnings
Rising costs and delayed production drive fair value cut for ASX iron ore player.
stocks
Global tensions drive profitability for ASX energy provider
Supply disruptions turbocharge refining profits and lift earnings forecasts for ASX energy share.
stocks
ASX energy share undervalued ahead of earnings
Pricing strength outweighs temporary production headwinds.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,321.40 | 24.30 | -0.26% |
| CAC 40 | 8,666.63 | 52.81 | 0.61% |
| DAX 40 | 26,202.35 | 201.04 | 0.77% |
| Dow JONES (US) | 54,085.88 | 907.47 | 1.71% |
| FTSE 100 | 10,879.38 | 21.68 | 0.20% |
| HKSE | 25,852.92 | 156.48 | -0.60% |
| NASDAQ | 26,584.99 | 671.10 | 2.59% |
| Nikkei 225 | 65,893.64 | 1,936.11 | 3.03% |
| NZX 50 Index | 13,944.47 | 41.01 | 0.29% |
| S&P 500 | 7,736.52 | 136.02 | 1.79% |
| S&P/ASX 200 | 9,143.40 | 33.10 | -0.36% |
| SSE Composite Index | 3,822.28 | 12.62 | 0.33% |